CerebrumIQ Reviews Spark Deeper Questions About What Intelligence Really Means
However, pregnant women are generally excluded from participation in these trials for ethical reasons. This means that there is a lack of randomised clinical data on the effects of the drug in human pregnancy. Non-clinical studies conducted in pregnant animal models which are used as a surrogate, are therefore important to investigate the effects of a drug in pregnancy. This type of data provides insights on the drug’s potential to interfere in human embryonic/fetal development because the mechanisms facilitating embryonic/fetal development are highly conserved through evolution and as a result there are many similarities between the response in the animal models and humans.
Lists of linear words does not engage the intuitive, right side of our brain. A much more effective way to do this is to use a technique called Mind Mapping®. Regular use of such visual, organic, branching techniques is brain-friendly, and encourages learning through visualisation and realisation of the interconnectedness of our internal and external worlds.
- The findings from clinical studies with regards to the risk of fetal death in association with in-utero exposure to oxcarbazepine are inconsistent.
- Individual pregnancy registry and population-based cohort studies have reported increased risks of fetal loss with carbamazepine compared with unexposed women with epilepsy (Artama et al 2013, Trivedi et al 2018).
- Singh M, Mishra A. Prenatal topiramate exposure induced developmental changes in rat brain.
- The first step in developing and testing a new drug is non-clinical research and assessing the safety and efficacy in both in vitro models (such as cell cultures) and several animal species, including pregnant animals, prior to First in Humans.
- A research study that tests the effectiveness and safety of medicines in humans.
Limited published non-clinical studies report of teratogenicity in rodents however, in company sponsored studies no teratogenicity was reported in rodents and rabbits at plasma concentrations far exceeding human therapeutic doses. In considering the conflicting data regarding the teratogenic potential of pregabalin, no firm conclusions can be drawn of its potential teratogenic effect. Prescribing trend data show that prescribing prevalence rates for pregabalin are high and have been increasing over time but this is reflective of the cerebrumiq increasing use in the pain and anxiety indications. In June 2019, the rate was 75.94 prescriptions per 10,000 eligible women of childbearing age women (CPRD GOLD), making pregabalin the second most frequently prescribed antiepileptic drug in women of childbearing age among the drugs which have been prioritised for review.
Clinical data or clinical studies
If 100 women take a valproate medicine during pregnancy about 10 of their babies will be born with physical birth abnormalities. And about 30 to 40 of the 100 children will go on to have disorders affecting their learning and thinking abilities, including autism. All doses of valproate carry a risk but the data support that the higher the dose of valproate, the higher the risks of birth abnormalities and effects on the child’s brain development. Two smaller epidemiological studies (Hunt et al 2008 and Wade, 2015) did not show an increased relative risk of small for gestational age but these studies may not have been adequately powered to detect an increase in risk.
Pervasive developmental disorders
- When we have this congruence in our society then we will find it also in our children.
- Although the risk was statistically significantly increased compared to the untreated control group, there was no difference compared with a levetiracetam exposed group and the available data for the latter does not appear to support an increased risk of fetal loss.
- The possibility of a dose-dependent risk is already reflected in the carbamazepine Summary of Product Characteristics.
- Overall, the data are supportive of a median prevalence of congenital malformations with topiramate of 4–5% and an increased risk compared with unexposed women with or without epilepsy.
This is because untreated epilepsy can cause harm to both the mother and her unborn baby. The pioneering work of Howard Gardner and Daniel Goleman’s book Emotional Intelligence have hopefully finally debunked the idea that we all possess a single innate intelligence or “IQ”. Gardner emphasises that we all have at least seven intelligences and each can be improved with practise. The “intelligences” are Logical/Mathematical, Linguistic, Physical /Kinesthetic, Musical, Visual/Spatial, Intrapersonal, and Interpersonal. The Logical/Mathematical relates to our ability to reason and calculate and is most developed in scientists, mathematicians, lawyers and judges. The Linguistic intelligence is our ability to read, write and communicate with words.
Fertilization and normal embryonic and early fetal development
Studies that explore a dose-dependent risk are very limited but where this was studied (Nulman et al 1997, Samren et al 1997, Kaneko et al 1999, Kaaja 2003, Hernandez-Diaz et al 2012) the data do not consistently show an association between dose and risk of major congenital malformations. Of these studies, only Samren 1997 and Kaneko et al 1999 reported a dose-effect. Samren conducted a very small study involving 33 phenytoin exposed pregnancies. Kaneko (132 exposed pregnancies), found a clear but not statistically significant positive trend between dose and incidence of malformation based on 132 phenytoin-exposed pregnancies. Overall, these data are inconsistent and too limited to draw conclusions on a dose-dependent risk of congenital malformations following phenytoin exposure in utero.